Press Releases from 2011

14. Dec. 2011 Evolva obtains patent coverage in Russia on EV-077 for use in complications of diabetes
8. Dec. 2011 Evolva to receive second milestone payment from Roche
15. Nov. 2011 EU approves use of Stevia in food and beverages
11. Nov. 2011 Alexandra Santana Sorensen to leave Evolva
7. Nov. 2011 Evolva receives clearance to move EV-077 into Phase IIa
12. Sep. 2011 Evolva announces interim results for first six months of 2011
18. Aug. 2011 Evolva Coordinated Sale Process To End
15. Aug. 2011 Evolva secures financing of up to CHF 30 million
3. Aug. 2011 Renowned Synthetic Biology and Metabolic Engineering Experts Jay Keasling and Douglas Cameron Join Evolva Scientific Advisory Board
25. Jul. 2011 Positive ex vivo data on EV-077 in diabetics presented at ISTH conference in Kyoto, Japan
15. Jul. 2011 Evolva completes Phase I studies with EV-077
8. Jul. 2011 Evolva completes Abunda acquisition
14. Jun. 2011 Evolva to receive first milestone payment from Roche
18. May. 2011 Evolva shareholders approve all Board proposals in AGM
17. May. 2011 Evolva’s major shareholders agree to continue the coordinated sale
2. May. 2011 Evolva appoints Norbert Bender as Chief Medical Officer
26. Apr. 2011 Evolva proposes two leading biotech and food ingredient executives to join its Board
5. Apr. 2011 Evolva to Acquire Abunda Nutrition
28. Mar. 2011 FDA clears Evolva’s IND for EV-077 in influenza
22. Mar. 2011 Evolva to enter the Swiss SPI stock index
17. Mar. 2011 Evolva announces financial results for 2010
7. Mar. 2011 BASF and Evolva enter into a collaboration to develop compounds applied to protect crops
24. Feb. 2011 Evolva announces pre-clinical efficacy data with EV-077 in influenza
13. Jan. 2011 Evolva enters into collaboration with International Flavors & Fragrances Inc.

Contact Information

Evolva SA
Duggingerstrasse 23
CH-4153 Reinach
Switzerland
Tel: +41 61 485 2000
Fax: +41 61 485 2001
Evolva A/S
Lersoe Parkallé 42-44
DK-2100 Copenhagen OE
Denmark
Tel: +45 35 200 230
Fax: +45 35 200 231
Evolva Biotech Private Limited
401 - 405, 4th Floor
Ticel Bio Park Ltd
Taramani Road, Taramani
Chennai 600 113
Tamil Nadu, India
Tel: +91 44 4297 1050
Fax: +91 44 4297 1060
Evolva, Inc. (Evolva USA)
2440 Embarcadero Way
Palo Alto
CA 94303
USA
Tel: +1 650 856 2436
Fax: +1 650 856 7950

General Enquiries: info@evolva.com • Business Enquiries: busdev@evolva.com • India Enquiries: info_india@evolva.com